Muscarinic autoinhibition release in mouse atria is not transduced through cyclic AMP or protein kinase C

被引:11
作者
Dawson, JJ [1 ]
Iannazzo, L [1 ]
Majewski, H [1 ]
机构
[1] PRINCE HENRYS INST MED RES,CLAYTON,VIC 3168,AUSTRALIA
来源
JOURNAL OF AUTONOMIC PHARMACOLOGY | 1996年 / 16卷 / 02期
关键词
D O I
10.1111/j.1474-8673.1996.tb00415.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
1 The present study investigated the second messenger pathways that may mediate muscarinic receptor autoinhibition of acetylcholine release in mouse atria. The stimulation-induced (S-I) outflow of radioactivity from mouse isolated atria incubated with [H-3]-choline was Ca2+ dependent and tetrodotoxin-sensitive and was used as an index of neuronal acetylcholine release. 2 The cell permeable analogue of cyclic AMP, 8-bromocyclic AMP (1 x 10(-3)M) enhanced the S-I outflow of radioactivity (33%), lower concentrations having no effect. Similarly, the adenylate cyclase activator forskolin (1x10(-5)M) had a small facilitatory effect on acetylcholine release. On the other hand the phosphodiesterase inhibitor 3-isobutylmethylxanthine (1 x 10(-4)M) had no effect on the S-I outflow of radioactivity. Together these results suggest that the adenylate cyclase/cyclic AMP system does not have an appreciable role in the modulation of acetylcholine release. 3 The protein kinase C activator phorbol dibutyrate (0.1-3 x 10(-6)M) enhanced the S-I acetylcholine release (maximally by 45%). The effects of phorbol dibutyrate were attenuated by the protein kinase inhibitor staurosporine (1 x 10(-7)M), which by itself had no effect on the S-I outflow of radioactivity. This latter result suggests chat there is no tonic activation of protein kinase C during acetylcholine release. 4 Atropine (1 x 10(-7)M) markedly enhanced (232%) the S-I outflow of radioactivity, presumably by preventing feedback inhibition on acetylcholine release through prejunctional muscarinic receptors. This effect is unlikely to involve adenylate cyclase or protein kinase C since it was far greater than the effects of activation of either system with forskolin and phorbol dibutyrate, respectively. Furthermore, the facilitatory effect of atropine was not attenuated by staurosporine, which although a protein kinase C inhibitor, is also an effective inhibitor of cyclic AMP dependent protein kinase (protein kinase A).
引用
收藏
页码:79 / 85
页数:7
相关论文
共 39 条
[1]   EFFECTS OF N-6,2'-O-DIBUTYRYLADENOSINE 3',5'-CYCLIC-MONOPHOSPHATE, ADENOSINE, AND OF OXOTREMORINE AND 3-ISOBUTYL-1-METHYLXANTHINE ON THE ELECTRICALLY EVOKED [H-3]ACETYLCHOLINE SECRETION IN THE GUINEA-PIG ILEUM MYENTERIC PLEXUS [J].
ALBERTS, P .
ACTA PHYSIOLOGICA SCANDINAVICA, 1989, 137 (04) :489-496
[2]   INTERACTION OF FORSKOLIN WITH THE EFFECT OF ATROPINE ON [H-3]ACETYLCHOLINE SECRETION IN GUINEA-PIG ILEUM MYENTERIC PLEXUS [J].
ALBERTS, P ;
OGREN, VR .
JOURNAL OF PHYSIOLOGY-LONDON, 1988, 395 :441-453
[3]  
Alberts P, 1982, Acta Physiol Scand Suppl, V506, P1
[4]   SECRETION OF ACETYLCHOLINE-H-3 FROM GUINEA-PIG ILEUM MYENTERIC PLEXUS IS ENHANCED BY 8-BR ADENOSINE 3',5'-CYCLIC-MONOPHOSPHATE BUT NOT CHANGED BY 8-BR GUANOSINE 3',5'-CYCLIC-MONOPHOSPHATE [J].
ALBERTS, P ;
STJARNE, L .
ACTA PHYSIOLOGICA SCANDINAVICA, 1982, 115 (02) :269-272
[5]  
ALBERTS P, 1987, INT S MUSC CHOL MECH, P19
[6]   PROTEIN KINASE-C AND PRESYNAPTIC MODULATION OF ACETYLCHOLINE-RELEASE IN RABBIT HIPPOCAMPUS [J].
ALLGAIER, C ;
DASCHMANN, B ;
HUANG, HY ;
HERTTING, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (03) :525-534
[7]   PROTEIN-KINASE-C ACTIVATION AND ALPHA-2-AUTORECEPTOR-MODULATED RELEASE OF NORADRENALINE [J].
ALLGAIER, C ;
HERTTING, G ;
HUA, YH ;
JACKISCH, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (01) :161-172
[8]   FORSKOLIN MODULATES ACETYLCHOLINE-RELEASE IN THE HIPPOCAMPUS INDEPENDENTLY OF ADENYLATE-CYCLASE ACTIVATION [J].
ALLGAIER, C ;
CHOI, BK ;
HERTTING, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 181 (03) :279-282
[9]  
BOGNAR IT, 1990, N-S ARCH PHARMACOL, V341, P22
[10]   LONG-TERM REGULATION OF SYNAPTIC ACETYLCHOLINE-RELEASE AND NICOTINIC TRANSMISSION - THE ROLE OF CYCLIC-AMP [J].
BRIGGS, CA ;
MCAFEE, DA ;
MCCAMAN, RE .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (02) :399-411